90 related articles for article (PubMed ID: 7522886)
1. In vitro properties of purified human stem cell candidates.
Lansdorp PM
J Hematother; 1993; 2(3):329-32. PubMed ID: 7522886
[TBL] [Abstract][Full Text] [Related]
2. Maintenance of hematopoiesis in serum-free bone marrow cultures involves sequential recruitment of quiescent progenitors.
Lansdorp PM; Dragowska W
Exp Hematol; 1993 Sep; 21(10):1321-7. PubMed ID: 7689481
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts?
Traycoff CM; Abboud MR; Laver J; Clapp DW; Hoffman R; Law P; Srour EF
Blood Cells; 1994; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
6. Age-related decline in proliferative potential of purified stem cell candidates.
Lansdorp PM; Dragowska W; Thomas TE; Little MT; Mayani H
Blood Cells; 1994; 20(2-3):376-80; discussion 380-1. PubMed ID: 7538342
[TBL] [Abstract][Full Text] [Related]
7. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
9. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
10. Expansion of mobilized peripheral blood progenitor cells under defined culture conditions rsing CD34+CD71-CD45- cells as a starting population.
Zech NH; Gunsilius E; Clausen J; Hoflehner E; Hoelzler K; Gastl G; Petzer AL
J Hematother Stem Cell Res; 2003 Aug; 12(4):367-73. PubMed ID: 12965074
[TBL] [Abstract][Full Text] [Related]
11. Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow.
Lansdorp PM; Dragowska W
J Exp Med; 1992 Jun; 175(6):1501-9. PubMed ID: 1375263
[TBL] [Abstract][Full Text] [Related]
12. Extensive proliferative capacity of single isolated CD34 human cord blood cells in suspension culture.
Xiao M; Broxmeyer HE; Horie M; Grigsby S; Lu L
Blood Cells; 1994; 20(2-3):455-66; discussion 466-7. PubMed ID: 7538351
[TBL] [Abstract][Full Text] [Related]
13. Proliferation of individual hematopoietic progenitors purified from umbilical cord blood.
Mayani H; Lansdorp PM
Exp Hematol; 1995 Dec; 23(14):1453-62. PubMed ID: 8542931
[TBL] [Abstract][Full Text] [Related]
14. Effects of mast cell growth factor, interleukin-3, and interleukin-6 on human primitive hematopoietic progenitors from bone marrow and cord blood.
Tsujino Y; Wada H; Misawa M; Kai S; Hara H
Exp Hematol; 1993 Sep; 21(10):1379-86. PubMed ID: 7689484
[TBL] [Abstract][Full Text] [Related]
15. Characterization of functionally distinct subpopulations of CD34+ cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines.
Mayani H; Dragowska W; Lansdorp PM
Blood; 1993 Nov; 82(9):2664-72. PubMed ID: 7693044
[TBL] [Abstract][Full Text] [Related]
16. Aspects of the biology of the neonatal hematopoietic stem cell.
Migliaccio AR; Baiocchi M; Durand B; Eddleman K; Migliaccio G; Adamson JW
Stem Cells; 1993 Jul; 11 Suppl 2():56-64. PubMed ID: 7691329
[TBL] [Abstract][Full Text] [Related]
17. Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules.
Huang S; Law P; Francis K; Palsson BO; Ho AD
Blood; 1999 Oct; 94(8):2595-604. PubMed ID: 10515863
[TBL] [Abstract][Full Text] [Related]
18. Can human hematopoietic stem cells be cultured ex vivo?
Verfaillie CM
Stem Cells; 1994 Sep; 12(5):466-76. PubMed ID: 7528589
[TBL] [Abstract][Full Text] [Related]
19. Lineage commitment in human hemopoiesis involves asymmetric cell division of multipotent progenitors and does not appear to be influenced by cytokines.
Mayani H; Dragowska W; Lansdorp PM
J Cell Physiol; 1993 Dec; 157(3):579-86. PubMed ID: 7504678
[TBL] [Abstract][Full Text] [Related]
20. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
